Stock listing
Intellia Therapeutics, Inc. (A2AG6H) Stock Price, News, Filings & Events
Selected listing: A2AG6H · LS · EUR · DE
This page tracks Intellia Therapeutics, Inc.'s A2AG6H:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AG6H:LS. A2AG6H:LS is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to A2AG6H:LS. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.
- Ticker
- A2AG6H:LS
- Asset type
- Stock
- Market cap
- $2.33B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Intellia Therapeutics, Inc. A2AG6H:LS stock context
This page tracks Intellia Therapeutics, Inc.'s A2AG6H:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AG6H:LS. A2AG6H:LS is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to A2AG6H:LS. Intellia Therapeutics, Inc. is a public biotechnology company listed on 6ix the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.
Research Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2AG6H:LS.
Intellia Therapeutics, Inc. company profile
View the public company page for Intellia Therapeutics, Inc. on 6ix.
Intellia Therapeutics, Inc. news
Read company news and market updates connected to Intellia Therapeutics, Inc..
Intellia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Intellia Therapeutics, Inc..
Alternate listings
NTLA:NASDAQ
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:GETTEX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
A2AG6H:LSX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
NTLA:BOATS
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:TRADEGATE
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:HAM
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
0JBU:LSE
GB · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:FWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:SWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:BX
CH · CHF
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:DUS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.
38I:MUN
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is A2AG6H:LS.